Educational information, not medical advice — ask your doctor or midwife.
Triphala is one of the most revered formulas in Ayurvedic medicine, composed of equal parts of three dried fruits: amalaki (Indian gooseberry), bibhitaki, and haritaki. It has been used continuously for over 2,000 years across India, Nepal, and Sri Lanka as a gentle daily tonic for digestion, detoxification, and longevity. Unlike many herbal preparations, Triphala is considered tridoshic — meaning it is believed to balance all three Ayurvedic body types — which helps explain its remarkably broad use.
Triphala works primarily by gently stimulating the muscles of the colon to encourage regular bowel movement without causing the harsh dependency associated with stimulant laxatives. Its rich mix of tannins, polyphenols, and vitamin C act as antioxidants throughout the digestive tract and bloodstream, helping to reduce inflammation and protect cells from everyday damage. It also appears to act as a prebiotic, feeding beneficial gut bacteria and improving the overall balance of the gut microbiome.
The traditional powder (churna) form is the most potent and allows flexible dosing — it can be mixed into warm water or honey. Capsules and tablets are more convenient and better for people sensitive to the bitter taste. Liquid extracts offer faster absorption. The powder form is preferred in classical Ayurveda because the taste itself is considered part of the therapeutic experience.
Triphala appears in the Charaka Samhita and Sushruta Samhita — two of the oldest Ayurvedic textbooks, dating back roughly 1,500–2,000 years. It is one of the few Ayurvedic formulas that has remained essentially unchanged in composition and use through millennia of practice. In traditional use, it was taken daily before bed to support gentle overnight detoxification and regular morning elimination.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.